# AFSTYLA Antihemophilic Factor (Recombinant), Single Chain

NDC: 69911-481
Generic name: ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
Labeler / Manufacturer: CSL Behring Lengnau AG
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20170328

FDA application: BLA125591

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69911-481"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69911-481